Another study showed that CCAT1 regulates miR-490-3p in ovarian cancer, indicating new therapeutic strategies [13], and then explored CCAT2′s co-expressed genes, suggesting targeting CCAT2 pathways for cancer therapy. Here, CCAT2 is linked to ovarian cancer.